XML 31 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive loss
Accumulated deficit
Balance at the beginning at Dec. 31, 2021 $ 109,700   $ 252,468 $ (119) $ (142,649)
Balance at the beginning (in shares) at Dec. 31, 2021   2,336      
Issuance of common stock under Equity Purchase Agreement(Value) 273   273    
Issuance of common stock under Equity Purchase Agreement (Share)   7      
Issuance of common stock under employee stock purchase plan 143   143    
Issuance of common stock under employee stock purchase plan (Share)   23      
Repurchase of early exercised stock options, shares   (1)      
Repurchase and cancelation of common stock (2,607)   (2,607)    
Repurchase and cancellation of common stock (Share)   (359)      
Vesting of early exercised stock options 101   101    
Stock-based compensation expense 4,517   4,517    
Other comprehensive loss (122)     (122)  
Net loss (36,004)       (36,004)
Balance at the end at Dec. 31, 2022 76,001   254,895 (241) (178,653)
Balance at the end (in shares) at Dec. 31, 2022   2,006      
Issuance of common stock under employee stock purchase plan 332   332    
Issuance of common stock under employee stock purchase plan (Share)   58      
Issuance of common stock upon option exercises 3   3    
Redemption of fractional shares due to reverse stock split, value (4)   (4)    
Repurchase of early exercised stock options, shares   (1)      
Repurchase and cancelation of common stock 0        
Vesting of early exercised stock options 32   32    
Stock-based compensation expense 4,372   4,372    
Other comprehensive loss 241     $ 241  
Net loss (43,042)       (43,042)
Balance at the end at Dec. 31, 2023 $ 37,935   $ 259,630   $ (221,695)
Balance at the end (in shares) at Dec. 31, 2023   2,063